Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
Stay current. Stay confident. Stay clinically sharp.
52 episodes. 30+ CE hours. $99 — less than $3 per hour.Weekly ACPE-accredited, relevant content you can watch, listen to, or download—anytime!
Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have… More Details
GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research.… More Details
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating… More Details
As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety… More Details
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures —… More Details
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures —… More Details
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance —… More Details
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance —… More Details
With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory… More Details
With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory… More Details
Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the… More Details
Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated… More Details
